Header Logo

Connection

JOSEPH JANKOVIC to Disease Progression

Back to Details
This is a "connection" page, showing publications JOSEPH JANKOVIC has written about Disease Progression.
JOSEPH JANKOVIC
Connection Strength
1.221
Disease Progression
  1. Tapping the Brakes on New Parkinson Disease Biological Staging. JAMA Neurol. 2024 Aug 01; 81(8):789-790.
    View in: PubMed
    Score: 0.147
  2. Slowing Parkinson's Disease Progression with Vaccination and Other Immunotherapies. CNS Drugs. 2022 04; 36(4):327-343.
    View in: PubMed
    Score: 0.124
  3. Parkinson's disease tremors and serotonin. Brain. 2018 03 01; 141(3):624-626.
    View in: PubMed
    Score: 0.094
  4. Natural history of multiple system atrophy in the USA: a prospective cohort study. Lancet Neurol. 2015 Jul; 14(7):710-9.
    View in: PubMed
    Score: 0.078
  5. Deep brain stimulation of the subthalamic nucleus for peripherally induced parkinsonism. Neuromodulation. 2014 Jan; 17(1):104-6.
    View in: PubMed
    Score: 0.067
  6. Early diagnosis and therapy of Parkinson's disease: can disease progression be curbed? J Neural Transm (Vienna). 2013 Jan; 120(1):197-210.
    View in: PubMed
    Score: 0.064
  7. Reflexive and volitional saccades: biomarkers of Huntington disease severity and progression. J Neurol Sci. 2012 Feb 15; 313(1-2):35-41.
    View in: PubMed
    Score: 0.061
  8. Diagnosis and treatment of psychogenic parkinsonism. J Neurol Neurosurg Psychiatry. 2011 Dec; 82(12):1300-3.
    View in: PubMed
    Score: 0.060
  9. Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Ann Neurol. 2011 Mar; 69(3):570-80.
    View in: PubMed
    Score: 0.058
  10. Alexia without agraphia in Creutzfeldt-Jakob disease. J Neurol Sci. 2007 Dec 15; 263(1-2):208-10.
    View in: PubMed
    Score: 0.045
  11. Medical management of levodopa-associated motor complications in patients with Parkinson's disease. CNS Drugs. 2007; 21(8):677-92.
    View in: PubMed
    Score: 0.043
  12. Long-term prognosis of patients with psychogenic movement disorders. Parkinsonism Relat Disord. 2006 Sep; 12(6):382-7.
    View in: PubMed
    Score: 0.042
  13. Searching for a relationship between manganese and welding and Parkinson's disease. Neurology. 2005 Jun 28; 64(12):2021-8.
    View in: PubMed
    Score: 0.039
  14. Progression of Parkinson disease: are we making progress in charting the course? Arch Neurol. 2005 Mar; 62(3):351-2.
    View in: PubMed
    Score: 0.038
  15. Essential tremor course and disability: a clinicopathologic study of 20 cases. Neurology. 2004 Oct 26; 63(8):1541-2; author reply 1541-2.
    View in: PubMed
    Score: 0.037
  16. Neuroprotection in Parkinson disease. Arch Intern Med. 2003 Jul 28; 163(14):1650-4.
    View in: PubMed
    Score: 0.034
  17. Functional decline in Parkinson disease. Arch Neurol. 2001 Oct; 58(10):1611-5.
    View in: PubMed
    Score: 0.030
  18. Tardive and idiopathic oromandibular dystonia: a clinical comparison. J Neurol Neurosurg Psychiatry. 2000 Feb; 68(2):186-90.
    View in: PubMed
    Score: 0.027
  19. A novel sublingual apomorphine treatment for patients with fluctuating Parkinson's disease. Mov Disord. 1999 Jul; 14(4):664-8.
    View in: PubMed
    Score: 0.026
  20. Bilateral hemifacial spasm: a report of five cases and a literature review. Mov Disord. 1999 Mar; 14(2):345-9.
    View in: PubMed
    Score: 0.025
  21. Tics secondary to craniocerebral trauma. Mov Disord. 1997 Sep; 12(5):776-82.
    View in: PubMed
    Score: 0.023
  22. Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits. Mov Disord. 2015 Dec; 30(14):1885-92.
    View in: PubMed
    Score: 0.020
  23. Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study. Ann Neurol. 2010 Jul; 68(1):18-27.
    View in: PubMed
    Score: 0.014
  24. The course of depressive symptoms in early Parkinson's disease. Mov Disord. 2009 Jul 15; 24(9):1306-11.
    View in: PubMed
    Score: 0.013
  25. Potential outcome measures and trial design issues for multiple system atrophy. Mov Disord. 2007 Dec; 22(16):2371-7.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.